Epigenetic–Metabolic Interplay in the DNA Damage Response and Therapeutic Resistance of Breast Cancer
Authors:
- Chandrima DasCDChandrima Das
- Swagata AdhikariSASwagata Adhikari
- Apoorva BhattacharyaABApoorva Bhattacharya
- Sanjukta ChakrabortySanjukta Chakraborty
- Payel MondalPMPayel Mondal
- Shalini S. YadavSYShalini S. Yadav
- Santanu AdhikarySASantanu Adhikary
- Clayton R. HuntCHClayton R. Hunt
- Kamlesh K. YadavKYKamlesh K. Yadav
- Shruti PanditaSPShruti Pandita
- Siddhartha RoySRSiddhartha Roy
- John A. TainerJTJohn A. Tainer
Open Access
- 18 January 2023
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 83 (5) , 657-666
Abstract
Therapy resistance is imposing a daunting challenge on effective clinical management of breast cancer. Although the development of resistance to drugs is multifaceted, reprogramming of energy metabolism pathways is emerging as a central but heterogenous regulator of this therapeutic challenge. Metabolic heterogeneity in cancer cells is intricately associated with alterations of different signaling networks and activation of DNA damage response pathways. Here we consider how the dynamic metabolic milieu of cancer cells regulates their DNA damage repair ability to ultimately contribute to development of therapy resistance. Diverse epigenetic regulators are crucial in remodeling the metabolic landscape of cancer. This epigenetic–metabolic interplay profoundly affects genomic stability of the cancer cells as well as their resistance to genotoxic therapies. These observations identify defining mechanisms of cancer epigenetics–metabolism–DNA repair axis that can be critical for devising novel, targeted therapeutic approaches that could sensitize cancer cells to conventional treatment strategies.Keywords
Funding Information
- NIH (RO1 CA129537)
This publication has 147 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA RepairCell, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- ATM activates the pentose phosphate pathway promoting anti‐oxidant defence and DNA repairThe EMBO Journal, 2010
- Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 2009
- Activity of ribonucleotide reductase helps determine how cells repair DNA double strand breaksDNA Repair, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Regulation of glutathione synthesisMolecular Aspects of Medicine, 2009
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- Phenotypic evaluation of the basal-like subtype of invasive breast carcinomaLaboratory Investigation, 2005